Formative Pharma

Formative Pharma is a UK-based specialty pharmaceutical company that focuses on the development and commercialization of value-added medicines. The company specializes in identifying opportunities to improve existing off-patent molecules through new formulations, delivery systems, or indications, particularly in niche therapeutic areas such as critical care. Founded by industry veterans with extensive experience in regulatory affairs and market access, Formative Pharma built a portfolio of complex medicines designed to address unmet patient needs. In June 2018, the company was acquired by Advanz Pharma (formerly Concordia International) to bolster its European pipeline and product development capabilities. Following the acquisition, Formative Pharma's assets and expertise were integrated into Advanz Pharma's global operations. The company is recognized for its ability to navigate complex regulatory pathways for repurposed pharmaceutical products.